0001961833-23-000001.txt : 20230202 0001961833-23-000001.hdr.sgml : 20230202 20230202125153 ACCESSION NUMBER: 0001961833-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230202 DATE AS OF CHANGE: 20230202 EFFECTIVENESS DATE: 20230202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Secretome Therapeutics, Inc. CENTRAL INDEX KEY: 0001961833 IRS NUMBER: 832097725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-472444 FILM NUMBER: 23579764 BUSINESS ADDRESS: STREET 1: 3060 PEGASUS PARK DR STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: 646.526.9628 MAIL ADDRESS: STREET 1: 3060 PEGASUS PARK DR STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 D 1 primary_doc.xml X0708 D LIVE 0001961833 Secretome Therapeutics, Inc. 3060 PEGASUS PARK DR BUILDING 6 DALLAS TX TEXAS 75247 646.526.9628 DELAWARE None None Corporation true 2018 VINEET JINDAL 3060 PEGASUS PARK DR BUILDING 6 DALLAS TX TEXAS 75247 Executive Officer Director WILLIAM NILAND 3060 PEGASUS PARK DR BUILDING 6 DALLAS TX TEXAS 75247 Director SUNJAY KAUSHAL 3060 PEGASUS PARK DR BUILDING 6 DALLAS TX TEXAS 75247 Director HENRIK RASMUSSEN 3060 PEGASUS PARK DR BUILDING 6 DALLAS TX TEXAS 75247 Director ANGELA SHEN 3060 PEGASUS PARK DR BUILDING 6 DALLAS TX TEXAS 75247 Director Biotechnology Decline to Disclose 06b false 2022-11-23 false true false 1 10888098 6854247 4033851 false 48 0 0 0 false Secretome Therapeutics, Inc. /s/Vineet Jindal Vineet Jindal Chief Executive Officer 2023-02-02